Core A: Administration
Core A: Administration
批准号:
10532091
负责人:
Deborah J Anderson
金额:
$21.26万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-09-14 至 2026-08-31
关键词:
AchievementAdherenceAntibodiesAntibody FormationAntigen TargetingAtopobium vaginaeAwardBiologicalBloodBostonClinicalClinical DataClinical ManagementClinical TrialsClinical Trials DatabaseCommunicationContraceptive AgentsContraceptive methodsDataDevelopmentEnsureEnvironmentExperimental DesignsFilmFundingGoalsGrantGuidelinesHIV-1HumanHuman Herpesvirus 2IgG1ImmobilizationIndividualIndustrializationIndustryInfertilityInfrastructureLeadershipLibrariesLiquid substanceMethodsMonitorMonoclonal AntibodiesNational Institute of Allergy and Infectious DiseaseNational Institute of Child Health and Human DevelopmentNicotianaPerformancePhase I Clinical TrialsPositioning AttributePreclinical TestingPreventionProgram ReviewsPublicationsReagentResearchResearch PersonnelResearch Project GrantsResource AllocationSafetyScheduleScientistSexually Transmitted DiseasesSiteSpecificitySperm AgglutinationStatistical Data InterpretationTechnologyTestingTranslational ResearchUnited States National Institutes of HealthUniversitiesVaginaVaginal Route of Drug AdministrationWomanbaseclinical databasedata acquisitiondata managementdata sharingexperienceinnovationmedical schoolsmeetingspathogenpre-clinicalprogramsresearch and developmentsperm cellstatistical servicestatisticssuccesssymposiumweb site
中文摘要
行政核心--摘要
波士顿大学医学院避孕研究中心汇集了
由临床、工业和基础科学家组成的经验丰富的团队开发和测试新的避孕产品ZB-
06,一种释放抗精子抗体的阴道膜,即人类避孕抗体(HCA)。Hca曾经是
最初从不育但其他方面健康的妇女的血液中分离出来,并以精子上的抗原为靶标
实现精子的快速凝集和固定。BUSM-CRC的成功取决于行政管理
在协调两种避孕措施发展方面提供科学和行政领导的核心
研究项目和一个避孕转化研究项目组成了该计划。这个
管理核心还将维护临床数据库,提供统计服务,并协调数据
和材料的获取和共享,使研究进展以一种综合迭代的方式满足
个别项目和方案里程碑,
行政核心的具体目标是:
1.提供科学的领导和行政监督。具体而言,行政核心将
建立一个执行委员会(EC),负责持续评估项目和核心里程碑、资源
对实验设计的分配和更改。行政核心还将召集外部
科学咨询小组(SAP)每年审查该计划。行政核心将促进
通过预定的电话会议和调查人员会议进行沟通,提供资金和
行政支持,并确保遵守机构和联邦指导方针。
2.协调数据和材料的获取和共享,以确保项目和计划
达到了里程碑。行政核心将负责试剂/研究材料和数据
管理和分享计划,以及监测里程碑成就。
3.管理两项临床试验的临床数据库和统计分析。
英文摘要
ADMINISTRATIVE CORE – ABSTRACT
The Contraception Research Center at Boston University School of Medicine (BUSM-CRC) brings together an
experienced team of clinical, industrial and basic scientists to develop and test a new contraceptive product, ZB-
06, a vaginal film that releases an antisperm antibody, Human Contraception Antibody (HCA). HCA was
originally isolated from the blood of an infertile but otherwise healthy woman and targets an antigen on sperm to
effect rapid sperm agglutination and immobilization. Success of the BUSM-CRC relies upon an Administrative
Core that provides scientific and administrative leadership in coordinating the two contraception development
research projects and one contraceptive translational research project that make up the program. The
Administrative Core will also maintain the clinical database and provide statistical services, and coordinate data
and materials acquisition and sharing so that the research progresses in an integrated iterative fashion to meet
individual project and programmatic milestones,
The Specific Aims of the Administrative Core are:
1. To provide scientific leadership and administrative oversight. Specifically, the Administrative Core will
establish an Executive Committee (EC) for ongoing assessment of project and core milestones, resource
allocation and changes to the experimental design. The Administrative Core will also convene an external
Scientific Advisory Panel (SAP) to review the program annually. The Administrative Core will facilitate
communication through scheduled conference calls and investigator meetings, provide financial and
administrative support, and insure adherence to institutional and federal guidelines.
2. To coordinate data and materials acquisition and sharing to insure that project and program
milestones are met. The Administrative Core will be responsible for the reagent/research material and data
management and sharing plan, and for monitoring milestone achievements.
3. To manage the clinical database and statistical analysis for the two clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic mRNA-mediated reversible immunocontraception
-
批准号:10018523
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2019
-
负责人:Deborah J Anderson
-
依托单位:
Synthetic mRNA-mediated reversible immunocontraception
-
批准号:10474919
-
项目类别:
-
资助金额:$68.75万
-
财政年份:2019
-
负责人:Deborah J Anderson
-
依托单位:
Administrative Core
-
批准号:10159118
-
项目类别:
-
资助金额:$51.52万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Preclinical Testing of Human Contraceptive Antibody (HCA) and HCA products
-
批准号:10159120
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive Antibody (HCA) through Clinical Trials
-
批准号:10532090
-
项目类别:
-
资助金额:$171.54万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Antibody-based Contraceptive MPTs: Preclinical and Clinical Research
-
批准号:10159117
-
项目类别:
-
资助金额:$181.36万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Project 3: Film Formulation, PK/PD and Safety Studies of ZB-06
-
批准号:10532094
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2018
-
负责人:Deborah J Anderson
-
依托单位:
Project Three: Assessing effects of anti-CD52g Mabs on STD pathogens in semen
-
批准号:9977700
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2017
-
负责人:Deborah J Anderson
-
依托单位:
Project One: Development and Testing of the HCA IVR
-
批准号:9548350
-
项目类别:
-
资助金额:$79.02万
-
财政年份:2017
-
负责人:Deborah J Anderson
-
依托单位:
Seminal Microbiota Associated with Inflammation and HIV Transmission
-
批准号:9221010
-
项目类别:
-
资助金额:$24.68万
-
财政年份:2016
-
负责人:Deborah J Anderson
-
依托单位:
Administrative Core
-
批准号:8900903
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2015
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8803840
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8302296
-
项目类别:
-
资助金额:$357.38万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8900899
-
项目类别:
-
资助金额:$240.83万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8706772
-
项目类别:
-
资助金额:$253.06万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Administrative Core
-
批准号:8209673
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8193671
-
项目类别:
-
资助金额:$303.32万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
MAbs in the Cervicovaginal Environment: Cellular Interactions and Host Defense
-
批准号:8209659
-
项目类别:
-
资助金额:$22.87万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8515314
-
项目类别:
-
资助金额:$309.83万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
Monoclonal Antibody-based Multipurpose Microbicides
-
批准号:8435056
-
项目类别:
-
资助金额:$2.61万
-
财政年份:2011
-
负责人:Deborah J Anderson
-
依托单位:
海外基金